Prescribing Drugs to Pregnant Women in Primary Healthcare

Yıl 2024, Cilt: 34 Sayı: 1, 144 - 146, 29.02.2024

İzzet Fidancı

https://doi.org/10.54005/geneltip.1213359

Öz

It is crucial for the health of both the mother and the fetus that drugs are only used during pregnancy when absolutely necessary. While appropriate drugs can be used for appropriate indications during pregnancy, it is preferably recommended not to use medication except for the necessary vitamins. In cases where the drug is to be used, the pregnancy category of the medication to be used should be known for the selection of the appropriate medication. Drugs that we regularly prescribe because they are safe should be high on our list of preferences, and if there is chronic drug use, the use of drugs must be regulated with caution and constantly reviewed for appropriateness.

Anahtar Kelimeler

Drug Utilization, Pregnancy, Teratogens, İlaç Kullanımı, Gebelik, Teratojenler

Destekleyen Kurum

-

Proje Numarası

-

Birinci Basamakta Gebeye İlaç Reçeteleme

Öz

Gebelik döneminde sadece gerekli durumlarda ilaç kullanılması hem anne hem de bebek sağlığı açısından çok önemlidir. Gebelik döneminde uygun endikasyonda uygun ilaçlar kullanılabileceği gibi tercihen gerekli olan vitaminlerin kullanımı dışını çıkılmayarak ilaç kullanılmaması önerilmektedir. İlaç kullanılacağı durumlarda ise uygun ilacın seçimi için kullanılacak ilacın gebelik kategorisi bilinmelidir. Güvenilir olması nedeniyle sıklıkla deneyimlediğimiz ilaçlar tercih sıralamamızda üstte yer almalıdır ve kronik ilaç kullanımı varsa dikkatli davranarak ilaçların kullanılmasının düzenlenmesi ve uygunluğunun sürekli gözden geçirilmesi gerekmektedir.

Anahtar Kelimeler

İlaç Kullanımı, Gebelik, Teratojenler

Proje Numarası

-

Kaynakça

• Miral M, Kızılkaya Beji N. Gebelikte İlaç Kullanımı ve Danışmanlık. Sağlık Bilimleri ve Meslekleri Dergisi. 2017;4(2):142-148.
• Zibellini J, Muscat DM, Kizirian N, Gordon A. Effect of health literacy interventions on pregnancy outcomes: A systematic review. Women and Birth 2021;34(2):180-186.
• Engeland A, Bjørge T, Klungsøyr K, et al. Trends in prescription drug use during pregnancy and postpartum in Norway, 2005 to 2015. Pharmacoepidemiology and drug safety 2018;27(9):995-1004.
• Çelikkalp Ü, Yorulmaz F. Gebe Sağlık Çalışanlarının Mesleki Riskleri Ve Koruyucu Yaklaşımlar. Sağlık Bilimleri ve Meslekleri Dergisi 2018;5(2):244-252.
• Akpınar E. Gebelikte İlaç Kullanımına Genel Bir Bakış. Ebelik ve Sağlık Bilimleri Dergisi 2021;4(3):330-339.
• Pereira CM, Pacagnella RC, Parpinelli MA, et al.Drug use during pregnancy and its consequences: a nested case control study on severe maternal morbidity. Revista Brasileira de Ginecologia e Obstetrícia 2018;40:518-526.
• Feibus KB. FDA’s Proposed Rule for Pregnancy and Lactation Labeling: Improving maternal child health through well-informed medicine use. J Med Toxicol 2008;4:284–8.
• Kaplan YC, Can H, Demir Ö, et al. İlaçların gebelikte kullanımlarına dair risk iletişiminde yeni dönem: FDA gebelik risk kategorileri değişiyor. Türk Aile Hekimliği Dergisi 2014;18(4):195-198.
• Ayuk PT. Use of novel drug therapies during pregnancy and breast-feeding. Case Rep Womens Health. 2023;38:e00511.
• Bookstaver PB, Bland CM, Griffin B, et al. A review of antibiotic use in pregnancy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2015;35(11):1052-1062.
• Alhasan MM, Cait AM, Heimesaat MM, et al. Antibiotic use during pregnancy increases offspring asthma severity in a dose‐dependent manner. Allergy 2020;75(8):1979-1990.
• Pernia S, DeMaagd G. The New Pregnancy and Lactation Labeling Rule. Pharmacy and Therapeutics 2016;41(11):713-715.
• Yang J, Xie RH, Krewski D, Wang YJ, et al. Exposure to trimethoprim/sulfamethoxazole but not other FDA category C and D anti-infectives is associated with increased risks of preterm birth and low birth weight. International Journal of Infectious Diseases 2011;15(5):e336-e341.
• Meyer A, Fermaut M, Drouin J, et al. Drug use for gastrointestinal symptoms during pregnancy: a French nationwide study 2010–2018. PloS one 2021;16(1):e0245854.
• Thélin CS, Richter JE. the management of heartburn during pregnancy and lactation. Alimentary Pharmacology & Therapeutics 2020;51(4):421-434.
• Ayele Y, Mekuria AN, Tola A, Mishore KM, Geleto FB. Prescription drugs use during pregnancy in Ethiopia: A systematic review and meta-analysis. SAGE Open Medicine 2020;8:2050312120935471.
• Huybrechts KF, Bateman BT, Hernández-Díaz S. Use of real-world evidence from healthcare utilization data to evaluate drug safety during pregnancy. Pharmacoepidemiol Drug Saf. 2019;28:906–922.
• Leek JC, Arif H. Pregnancy Medications. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan [cited 2022 Nov 08]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507858/
• Black E, Khor KE, Kennedy D, Chutatape A, Sharma S, Vancaillie T, Demirkol A. Medication Use and Pain Management in Pregnancy: A Critical Review. Pain Pract, 2019;19:875-899.
• FDA/CDER SBIA Chronicles. Drugs in Pregnancy and Lactation: Improved Benefit-Risk Information [Internet]. [cited 2022 Nov 08]. Available from: https://www.fda.gov/files/drugs/published/%22Drugs-in-Pregnancy-and-Lactation--Improved-Benefit-Risk-Information%22-January-22--2015-Issue.pdf
• Delaney AL, Singleton G. Information and relationship functions of communication between pregnant women and their health care providers. Communication studies 2020;71(5):800-822.
• Ivry T, Teman E. Shouldering Moral Responsibility: The Division of Moral Labor among Pregnant Women, Rabbis, and Doctors. American Anthropologist 2019;121:857-869.
• Garbers S, Falletta KA, Srinivasulu S, et al. “If You Don't Ask, I'm Not Going to Tell You”: Using Community-Based Participatory Research to Inform Pregnancy Intention Screening Processes for Black and Latina Women in Primary Care. Women's Health Issues 2020;30(1), 25-34.
• Bruno LO, Simoes RS, de Jesus Simoes M, Girão MJBC, Grundmann O. Pregnancy and herbal medicines: an unnecessary risk for women's health—a narrative review. Phytotherapy Research 2018;32(5):796-810.
• Vitalone A, Allkanjari O, Durazzi F, Guizzetti M, Aleandri V. The use of herbal products during pregnancy: which is the risk perception. Am. J. Phytomed. Clin. Ther 2021;9(1):1-8.
• Ahmed M, Hwang JH, Hasan MA, Han D. Herbal medicine use by pregnant women in Bangladesh: a cross-sectional study. BMC complementary and alternative medicine 2018, 18(1), 1-9.
• Ralston ER, Smith P, Chilcot J, Silverio SA, Bramham K. Perceptions of risk in pregnancy with chronic disease: A systematic review and thematic synthesis. PloS one 2021;16(7):e0254956.
• Lee IL, Purbrick B, Barzi F, et al. Cohort profile: the pregnancy and neonatal diabetes outcomes in remote Australia (PANDORA) study. International journal of epidemiology 2018;47(4):1045-1046h.
• Yılmaz M, Yılmaz A, Özyörük M. Akılcı ilaç kullanımı: Düzce’de Aile Hekimlerinin bilgi ve davranışları. Türk Aile Hek Derg 2018; 22 (1): 20-27.
• Dathe K, Schaefer C. The Use of Medication in Pregnancy. Dtsch Arztebl Int. 2019 Nov 15;116(46):783-790.
• Little BB. Drugs and Pregnancy: A Handbook (2nd ed.). CRC Press; 2022.